Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 5.55
+0.35 (6.73%)
Aug 14, 2025, 4:42 PM GMT+1
Shield Therapeutics Market Cap
Shield Therapeutics has a market cap or net worth of 57.81 million as of August 14, 2025. Its market cap has increased by 178.96% in one year.
Market Cap
57.81M
Enterprise Value
73.67M
Revenue
25.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.55
Market Cap Chart
Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 57.81M, a decrease of -65.95%. That is a compound annual growth rate of -10.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 57.81M | 173.80% |
| Dec 31, 2024 | 21.12M | -59.70% |
| Dec 29, 2023 | 52.40M | 186.53% |
| Dec 30, 2022 | 18.29M | -80.96% |
| Dec 31, 2021 | 96.06M | 28.62% |
| Dec 31, 2020 | 74.69M | -64.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.13B |
| GSK plc | 56.32B |
| Haleon | 31.67B |
| Smith & Nephew | 11.73B |
| ConvaTec Group | 4.65B |
| Hikma Pharmaceuticals | 3.95B |
| Oxford Nanopore Technologies | 2.01B |
| HUTCHMED (China) | 1.93B |